WO2005095432A1 - 5α-プレグナン誘導体の製造方法 - Google Patents
5α-プレグナン誘導体の製造方法 Download PDFInfo
- Publication number
- WO2005095432A1 WO2005095432A1 PCT/JP2005/006819 JP2005006819W WO2005095432A1 WO 2005095432 A1 WO2005095432 A1 WO 2005095432A1 JP 2005006819 W JP2005006819 W JP 2005006819W WO 2005095432 A1 WO2005095432 A1 WO 2005095432A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- hydroxyl
- compound
- general formula
- substituent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to a method for producing a 5a-predanane derivative useful as a squalamine synthesis intermediate.
- Hydroxy-20-methyl-5 ⁇ -predan-3-one (WO 03/51904) is known to be a useful intermediate which can be led to squalamine in a relatively short step.
- a method for producing (2 OS) -21-tert-butyldimethylsilyloxy-17 ⁇ -hydroxy-20-methyl-5 ⁇ -predana-13-one includes (20S) -7 ⁇ , 2 1-Dihydroxy-1-methyl-predana-1,4-gen-1-3-one was reduced in the same manner as above to give (2 OS) -7 a, 21-dihydroxy-1-20-methyl-5 a-predana-3-one. Thereafter, a method of protecting the hydroxyl group at the 21-position with a tert-butyldimethylsilyl group (WO 03/51904) is known.
- the above-described conventional reaction uses an unsaturated ketone having a carbon-carbon double bond at at least the 4th and 5th positions as a starting material to obtain a ketone derivative which is stereoselectively converted to a 5 ⁇ -isomer. This corresponds to the so-called partial reduction of converting unsaturated ketone to saturated ketone.
- the alcohol is formed by further reducing the saturated ketone as a side reaction. In order to suppress this side reaction, it is important to carry out the reaction using an amount of reducing agent close to the equivalent required for partial reduction, but in the conventional reaction, a large excess of metallic lithium is used. ing.
- the present inventors have found that the low yield of the conventional method is due to the presence of a hydroxyl group at the 21-position of the raw material predanane derivative, that is, the high reactivity of the reducing agent metal lithium at the 21-position.
- the primary hydroxyl group decomposes and loses the reducing ability, so that an excess amount of lithium must be used.
- the primary hydroxyl group also acts as a proton donor during the reduction reaction, resulting in a reaction. Was found to have caused further alcohol by-products due to further progress.
- the present inventors performed a reduction reaction using a compound in which the hydroxyl group at the 21-position was protected as a starting material to suppress the decomposition of the reducing agent by the hydroxyl group and the action as a proton supplier.
- the amount of the reducing agent used can be significantly reduced compared to the conventional method, and the reduction of the saturated ketone can be significantly suppressed, so that the desired product, 5a-saturated ketone, can be obtained in high yield.
- the 5 ⁇ -11-one-3-one form whose chemical structure closely resembles that of the target product, 5 ⁇ -saturated ketone, remains as an impurity, and its separation and removal is usually performed by recrystallization or column chromatography. It turned out to be a problem that the purification method was extremely difficult. This is a very problematic method for producing pharmaceutical intermediates, which usually require high-purity products.
- an object of the present invention is to provide a method for producing (20S) -7 ⁇ , 21-dihydroxy_20-methylpredana-13-one derivative which is useful as an intermediate of squalamine. It is an object of the present invention to provide a method that makes it unnecessary to remove 5 ⁇ ; — 1-en-3-one, which is a difficult impurity.
- the inventor of the present invention carried out a reduction reaction of a mixture of 5a-saturated ketone compound as an objective substance and 5 ⁇ -1-en-3-one compound as an impurity to obtain 5a-saturated ketone compound in the mixture. without impairing the alpha-saturated ketones, 5 alpha - 1-En 3-one body by reducing only carbon one-carbon double bond, it is possible to convert to the desired product 5 alpha-saturated ketones And completed the present invention.
- the present invention is as follows.
- R 1 and R 2 each independently represent a hydrogen atom or a hydroxyl-protecting group.
- R 1 and R 2 each independently represent a hydrogen atom or a hydroxyl-protecting group.
- R 11 and R 12 each independently represent a hydrogen atom or a hydroxyl-protecting group.
- 5a-Predanane derivative (hereinafter sometimes referred to as compound (III) in the present specification) ))
- Manufacturing method (2) The production method according to the above (1), wherein R 2 and R 12 are hydrogen atoms.
- R 1 and R 11 are a trisubstituted silyl group (the trisubstituted silyl group is an alkyl group which may have a substituent, an aryl group which may have a substituent, (3) having three identical or different substituents selected from the group consisting of an optionally substituted alkoxyl group and an optionally substituted aryloxy group.).
- (20 S) -7 CK, 21-dihydroxy-20-methyl-5 ⁇ ; -predana-3-one derivative (5 ⁇ -saturated ketone compound) is mixed and separated and removed.
- Difficult (2 OS) -7 ⁇ , 21-dihydroxy-1 20-methyl-5 ⁇ -predaner-11-one-3-one derivative was subjected to a reduction reaction in the form of a mixture.
- the 5 alpha a target product - without compromising saturated ketone bodies, the 5 alpha - 1 one En-3-one body by reducing only carbon one-carbon double bond, the desired product 5 alpha-saturated ketones Can be converted and used effectively.
- a compound in which the hydroxyl group at the 21-position is protected is used as a raw material compound to use a reducing agent.
- the amount can be reduced, and the by-product of the alcohol form due to the further progress of the reaction can be suppressed, and the 5a-predane derivative useful as a squalamine production intermediate can be produced in high yield.
- R 2, 11, the protecting group of R 12, R 21, R 22 , R 31 and R 32 are tables to hydroxyl, any such protecting group as long as it acts as a protecting group for a hydroxyl group
- An alkyl group which may have a substituent an acyl group which may have a substituent (for example, a formyl group, an alkyl group which may have a substituent, An optionally substituted alkoxycarbonyl group, an optionally substituted arylcarbonyl group, etc.); an optionally substituted alkoxy group, an optionally substituted alkoxy group;
- the alkyl group as a part of the alkoxy group of the silyl group, the aryl group of the trisubstituted silyl group, and the alkyl group of the aryl group which the aryloxy group may have may be linear, branched or branched.
- It may be cyclic, and preferably has 1 to 12 carbon atoms. More preferably, it is 1 to 8.
- alkyl group examples include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a hexyl group, an octyl group, a dodecyl group, a cyclopentyl group and a cyclohexyl group.
- the above-mentioned alkyl group may have a substituent.
- substituents There is no particular limitation on the number of substituents. A force of 1 to 6 is preferable. When the number is 2 or more, they may be the same or different. Examples of such a substituent include a phenyl group, a tolyl group, a methoxyphenyl group, a -to-phenyl group, a naphthyl group, and a fluorenyl group having 6 to 12 carbon atoms, preferably 6 to 10 carbon atoms.
- An aryl group which may have a substituent a butyl group or the like having 2 to 12 carbon atoms, preferably 2 to 10 carbon atoms, and an alkenyl group which may have a substituent; methoxy group, ethoxy group Group, propoxy group, isopropoxy group, butoxy group, isoptoxy group, tert-butoxy group, hexyloxy group, octyloxy group, dodecyloxy group, cyclopentyloxy group, cyclohexyloxy group, etc.
- Alkoxyl group having 1 to 12 carbon atoms, preferably 1 to 8 carbon atoms (the alkoxyl group forms a ring structure together with an alkyl group which is a hydroxyl-protecting group)
- an alkyl group which is a hydroxyl-protecting group For example, a tetrahydropyran ring, a tetrahydrofuran ring, etc.); a benzyloxy group or the like having 7 to 12 carbon atoms, preferably a 7 to 11 aralkyloxy group; an aryloxy group or the like having 2 to 2 carbon atoms. 12 and preferably 2 to 8 alkenyl groups; phenyl groups and naphthyloxy groups having 6 to 12 carbon atoms, preferably 6 to 10 carbon atoms and optionally substituted aryloxy groups And the like.
- alkenyl group as an optionally substituted substituent
- alkenyl group as an optionally substituted aryloxycarbonyl group
- aryl, alkoxyl or aryloxy group as a trisubstituted silyl group
- alkenyl group as a substituent which may have a linear, branched or cyclic structure, preferably having 2 to 12 carbon atoms, more preferably 2 to 8 carbon atoms. More preferred.
- alkenyl groups include examples thereof include a butyl group, a 1-methylvinyl group, a 1-propenyl group, a 1-otathenyl group, a 1-dodecenyl group, a 1-cyclopentyl group, a 1-cyclohexyl group, and the like.
- the above alkyl group may have a substituent.
- the number of substituents is not particularly limited, but is preferably 1 to 6, and when two or more, they may be the same or different.
- Examples of such a substituent include a phenyl group, a tolyl group, a methoxyphenyl group, a nitrophenyl group, a naphthyl group, a fluorenyl group and the like having 6 to 12 carbon atoms, preferably 6 to 10 carbon atoms.
- Aryl group which may have a methoxy group, a ethoxy group, a propoxy group, an isopropoxy group, a butoxy group, an isobutoxy group, a tert-butoxy group, a hexyloxy group, an octyloxy group, a dodecyloxy group, a cyclopentyloxy group
- a linear, branched or cyclic alkoxyl group such as a cyclohexyloxy group having 1 to 12, preferably 1 to 8 carbon atoms; a benzyloxy group or the like having 7 to 12 carbon atoms, preferably 7 to 1
- An aralkyloxy group having 1 to 2 carbon atoms such as an aryloxy group, preferably 2 to 8 carbon atoms; a phenoxy group and a naphthyl group Okishi is 6-1 2 carbon atoms, such groups, preferably 6-1 0, and the like may Ariruokishi group which may have a
- R 1, R 2, R: ⁇ R 1 2, R 2 1, R 2 2, Ariru group Contact Yopi Ashiru group as part of Ashiru group as a protecting group of R 3 1 and R 3 2 represents a hydroxyl group
- the aryl group, the alkoxyl group, and the aryl group which the aryloxy group may have may preferably have 6 to 10 carbon atoms.
- a phenyl group, a naphthyl group and the like may be substituted. I can do it.
- the above aryl group may have a substituent.
- substituents There is no particular limitation on the number of substituents. 1S to 1S are preferred, and in the case of 2 or more, they may be the same or different. Or Such substituents include, for example, methyl, ethyl, propyl, isopropyl
- alkyl group which may have a substituent among the hydroxyl-protecting groups represented by R 1 , R 2 , R 11 R 12 , R 21 , R 21 , R 22 , R 31 and R 32 include , Methyl group, ethyl group, tert-butyl group, methoxymethyl group, tert-butoxymethyl group, benzyloxymethyl group, 2-tetrahydrovinylyl group, 2-tetrahydrofuraninole group, 1-ethoxyhexyl group, 1-hydroxyl group Benzyloxy group, benzyl group, p-methoxybenzyl group, p-nitrobenzyl group, trityl group, and the like, methyl group, ethyl group, methoxymethyl group, 2-tetrahydrobilanyl group, A 2-tetrahydrofurayl group and a 1-ethoxyhexyl group are preferred.
- acyl group examples include formyl group, acetyl group and propyl group.
- R 1 , R 2 , R 11 , R 12 , R 2 ⁇ R 22 , R 31 and R 32 are methoxycarbonyl group, ethoxycarbonyl group, propoxy group, isopropoxy group / reponinole group, putoxycanolepon / le group, isoptoxycanolepon / re group, tert-butoxycarbonyl Group, hexyloxycarbonyl group, octyloxycarbonyl group, dodecyloxycarbinole group, cyclopentyloxycarboyl group, cyclohexyloxycarbonyl group, benzyloxycarbonyl group, —methoxybenzylo group Methoxycarbonyl, fluorenylmethoxycarbonyl, p-trobenzyloxycarbonyl, aryloxycarbonyl, etc. Force / Repoyur
- hydroxyl-protecting groups represented by R 1 , R 2 , 11 , R 12 , R 21 , R 22 , R 31 and R 32 specific examples of the optionally substituted aryloxy group are as follows. And a phenoxycarbonyl group, a p-ditrophenoxycarbonyl group and the like, and a phenoxycarponyl group is preferable.
- specific examples of the carpamoyl group include any hydrogen atom of a nitrogen atom, such as methyl.
- the trisubstituted silyl group include a trimethylsilyl group, a triethylsilyl group, a triisopropylsilyl group, a dimethylisopropylsilyl group, a methylisopropylsilyl group, a tert-butyldimethylsilyl group, and a tert-butyl A diphenylphenylsilyl group, a tribenzylsilyl group, a tert-butylmethoxyphenylsilyl group, and the like; a tert-butyldimethylsilyl group, a triethylsilyl group, and a triisopropylsilyl group are preferable, and a tert-butyldimethylsilyl group is more
- a trisubstituted silyl group is preferable, and among them, a tert-butyldimethylsilyl group is more preferable.
- the hydroxyl group at the 7-position in the mixture of compound (I) and compound (II) or the mixture of compound (IV) and compound (V) may or may not be protected. It is preferably unprotected from the viewpoint that the introduction reaction of the group can be omitted. That is, as R 2 , R 12 , R 22 and R 32 , a hydrogen atom is preferable. '
- the reduction method applicable to the method for producing compound (VI) by reducing the compound is, for example, catalytic reduction using a transition metal catalyst, reduction using a hydride reducing agent, and action of an alkali metal or alkaline earth metal. Reduction method.
- catalytic reduction using a transition metal catalyst is preferred from the viewpoint of suppressing the reduction of ketones and selectively reducing only carbon-carbon double bonds.
- catalytic reduction using a transition metal catalyst which is a preferred embodiment, will be described, but the reduction step is not limited thereto.
- the catalytic reduction is carried out by reacting a mixture of compound (I) and compound (II) or a mixture of compound (IV) and compound (V) with a reducing agent in the presence of a transition metal catalyst.
- Examples of the metal species of the transition metal catalyst used for catalytic reduction include ruthenium and rhodium. , Iridium, nickel, palladium, platinum and the like. Of these, nickel, palladium, and platinum are preferred, and palladium is most preferred.
- the form of the transition metal catalyst may be a complex catalyst that dissolves in the reaction system (eg, tetrakistripheninole phosphine palladium, palladium acetate), or a heterogeneous catalyst that does not dissolve in the reaction system (eg, palladium carbon, palladium hydroxide, palladium black, oxidation) Platinum) may be used, but a heterogeneous catalyst which can be easily separated from the reaction system, among which palladium ion and palladium black are preferred.
- a complex catalyst that dissolves in the reaction system eg, tetrakistripheninole phosphine palladium, palladium acetate
- a heterogeneous catalyst that does not dissolve in the reaction system eg, palladium carbon, palladium hydroxide, palladium black, oxidation
- the amount of the transition metal catalyst used depends on the ratio of the compound (III) or compound (V) mixed in the raw material mixture, but is usually 0.01 to 100% by mass based on the total mass of the raw material mixture. And preferably in the range of 0.1 to 10% by mass.
- Examples of the reducing agent include molecular hydrogen, formic acid and salts thereof, and molecular hydrogen is preferable.
- Hydrogen partial pressure in the case of using molecular hydrogen as a reducing agent is preferably in the range of l X l 0 4 ⁇ l X 10 7 P a, in the range of 1 X 10 5 ⁇ 1 X 10 6 P a Is more preferable.
- the reaction temperature of the catalytic reduction is preferably in the range of 0 ° C. to 150 ° C., more preferably in the range of 20 ° C. to 100 ° C.
- the reaction time varies depending on the reaction conditions, but is preferably in the range of 0.1 to 20 hours, more preferably in the range of 1 to 10 hours.
- the catalytic reduction reaction is usually performed in the presence of a solvent.
- the solvent is not particularly limited as long as it does not adversely affect the reaction.
- examples of the solvent include tetrahydrofuran, getyl ether, diisopropyl ether, methyl tert-butylinoleatenoate, cyclopropylmethyletheneole, dimethoxetane, and 1,4-dioxane.
- Ether saturated aliphatic hydrocarbons such as pentane, hexane, heptane, and octane; aromatic hydrocarbons such as benzene, toluene, xylene, and mesitylene; esters such as methyl acetate, ethyl acetate, butyl acetate, and methyl benzoate; Alcohols such as methanol, ethanol, 1-pro / c-nore, 2-propanol, 1-ptanol, 2-ptanol, 1-octanol; alcohols such as acetonitrile; N, N And amides such as dimethylformamide and N-methylpyrrolidone; and dimethylsulfoxide.
- saturated aliphatic hydrocarbons such as pentane, hexane, heptane, and octane
- aromatic hydrocarbons such as benzene, toluene, xylene, and mesity
- ethers such as tetrahydrofuran, getyl ether, diisopropyl ether, methylinole tert-peptinole ether, cyclopropinolemethinole ether, dimethoxetane, and 1,4-dioxane are preferred, and tetrahydrofuran is preferred. Is more preferred.
- the amount of the solvent used is not particularly limited, but is preferably in the range of 1 to 200 times by mass, more preferably 3 to 50 times by mass, based on the total mass of the raw material mixture.
- the method of isolating and purifying the compound (III) or compound (VI) obtained by the reduction reaction is not particularly limited, and a method generally used for isolating and purifying an organic compound can be employed. For example, after removing the catalyst and performing extraction, the compound (IzI) or compound (VI) is isolated by recrystallization or column chromatography.
- the protecting group of the hydroxyl group represented by R 1 and R 2 in the mixture of the compound (I) and the compound (II) is the same as that of the hydroxyl group represented by R 11 and R 12 in the compound (III). It may be the same as or different from the protecting group.
- the hydroxyl-protecting groups represented by R 21 and R 22 in the mixture of compound (IV) and compound (V) are the same as the hydroxyl-protecting groups represented by R 31 and R 32 in compound (VI). Or may be different. That is, the protecting group of the hydroxyl group represented by RR 2 , R 21 and R 22 may be arbitrarily changed by performing the reduction step within a range where deprotection is possible. For example, a crotonyl group may be changed to a ptanoyl group by a reduction reaction.
- the protecting group of the hydroxyl group represented by RR 2 , R 21 and R 22 may be deprotected by performing the reduction step.
- the reaction conditions used for deprotection of the hydroxyl-protecting group are not particularly limited. Normally used reaction conditions can be selected and used according to the type of the protecting group. For example, when the protecting group for the hydroxyl group is a tri-substituted silyl group, which is a preferred embodiment, the compound (VI) can be deprotected by reacting the compound (VI) with an acid or a fluoride salt.
- the embodiment will be described, but the deprotection reaction is not limited thereto.
- the type of acid is not particularly limited, and examples thereof include inorganic acids such as hydrochloric acid, sulfuric acid, hydrofluoric acid, and hydrobromic acid; and organic acids such as acetic acid, trifluoroacetic acid, p-toluenesulfonic acid, and methanesulfonic acid.
- examples of the fluoride salt include tetrabutylammonium fluoride, potassium fluoride, sodium fluoride and the like.
- the amount of the acid to be used is in the range of 0.1 to 10 gil, more preferably 0.1 to 5 mol, per mol of compound (VI).
- the amount of the fluoride salt used is determined by the number of protecting groups to be deprotected contained in the compound (VI). It is preferably in the range of 1 to 10 moles per one protecting group, and more preferably in the range of 1 to 5 moles.
- the deprotection reaction may be performed in the presence of a solvent.
- the solvent that can be used is not particularly limited, as long as it does not adversely affect the reaction.
- ethers such as 4-dioxane; saturated aliphatic hydrocarbons such as pentane, hexane, heptane and octane.
- ethers such as tetrahydrofuran, getyl ether, diisopropinole ether, methinolate tert-petit / leet ether, dimethoxyethane and 1,4-dioxane are preferable, and tetrahydrofuran is more preferable.
- a solvent When a solvent is used, its use amount is not particularly limited, but is preferably in the range of 1 to 100 times by mass, and more preferably in the range of 3 to 50 times by mass, relative to compound (VI).
- the reaction temperature is preferably from 120 ° C to 120 ° C. (: More preferably in the range of 0 ° C to 80 ° C.
- the reaction time is preferably in the range of 0.1 to 20 hours. And more preferably in the range of 1 to 10 hours.
- the method for isolating and purifying the compound (VII) thus obtained is not particularly limited.
- a method usually used for isolation and purification of an organic compound can be employed. For example, after performing an extraction operation and the like, compound '(VII) can be isolated and purified by an operation such as recrystallization or column chromatography.
- the method for producing a mixture of the compound (I) and the compound (II) or a mixture of the compound (IV) and the compound (V), which is a raw material compound in the present invention is, for example, (20S) -7 ⁇ , 21 -Dihydroxy-20-methylpredaner 1,4-dien-3-one or a derivative in which the 21-hydroxyl group is protected by a protecting group (hereinafter referred to as 1,4-gen-1-3-derivative) is added to lithium, sodium, It can be produced by reacting an alkali metal such as potassium or a metal element such as an alkaline earth metal such as magnesium, calcium, strontium and barium. Among these, alkali metals such as lithium, sodium and potassium are preferred, and lithium is more preferred.
- the amount of the alkali metal or alkaline earth metal used is such that the reduction of the carbon-carbon double bond at positions 4 and 5 of the 1,4-dien-3-one derivative is almost complete, and The amount is not particularly limited as long as it can be controlled to such an extent that a one-carbon double bond partially remains.
- the above-mentioned 1,4-dien-3-one derivative is usually used. It ranges from 0.8 to 2.5 times the amount required to reduce two carbon-carbon double bonds. If the amount of the alkali metal or alkaline earth metal used is smaller than the range, the reduction of the carbon-carbon double bond at the 4- and 5-positions of the 1,4-1-gen-3-one derivative tends to be incomplete. If it is larger, side reactions such as ketone reduction tend to proceed.
- the reaction temperature is preferably in the range from 100 ° C to 50 ° C, more preferably in the range from 150 ° C to 20 ° C.
- the reaction time varies depending on the reaction conditions, but is preferably in the range of 0.1 to 20 hours, more preferably in the range of 1 to 10 hours, from an industrial viewpoint.
- the reaction is performed in the presence of ammonia and z or amine.
- amine for example, primary amines such as methylamine, ethylamine, isopropylamine, and butyramine; secondary amines such as dimethylamine, getylamine, disopropylamine, pyrrolidine, and piperidine; ethylenediamine, diaminopropane, Linear, branched or cyclic amines having 1 to 6 carbon atoms, such as polyvalent amines such as N, N, -dimethylethylenediamine; etc.
- ammonia is preferred.
- the amount of ammonia and Z or amine to be used is preferably in the range of 1 to 100 times by mass, more preferably in the range of 3 to 50 times by mass relative to the 1,4-dien-3-one derivative. .
- the type of the proton donor is not particularly limited, and examples thereof include inorganic acids such as hydrochloric acid, sulfuric acid, and carbonic acid, and carboxylic acids such as formic acid, acetic acid, and benzoic acid, and ammonium salts or amine salts thereof; water; alcohol; The use of is preferred.
- Alcohols include, for example, primary alcohols such as methanol, ethanol, 1-propanol, 1-ptanol, 1-octanol and 1-dodecanol; 2-propanol, 2-butanol, 3-pentano, cyclopentano Secondary alcohols such as mono-, cyclohexanol and 2-octanol; tertiary alcohols such as tert-butanol, tert-amyl alcohol, 2-methylhexanol and 1-methylcyclohexanol; ethylene glycol , 1,4-heptanediol, 2,4-pentanediol, and polyhydric alcohols such as glycerin; and linear, branched or cyclic alcohols having 1 to 12 carbon atoms. Of these, tertiary alcohols are preferred, and tert-butanol is more preferred.
- the amount of proton donor used is usually in the range of 1.5 to 3 moles per carbon-carbon double bond to be reduced.
- the time at which the proton donor is added to the reaction system is not particularly limited.
- the 1,4-dien-3-one derivative may be added to the reaction system before reacting with the alkali metal or the alkaline earth metal.
- Addition method, or the 1,4-1-1-3-one derivative is an alkali metal
- the method can be arbitrarily selected from a method of adding to the reaction system after reacting with the alkaline earth metal, and the former method is preferable.
- the reaction may be performed in the presence of a solvent.
- the solvent that can be used is not particularly limited as long as it does not adversely affect the reaction.
- examples include tetrahydrofuran, methyl ether, diisopropyl ether, methyl tert-butylinoleatenoate, pentyl methyl ether, dimethoxyethane, and dimethoxyethane.
- Ethers such as 1,4-dioxane; saturated aliphatic hydrocarbons such as pentane, hexane, heptane, and octane.
- ethers such as tetrahydrofuran, getyl ether, disopropyl ether, methyl / latet-ptinole ether, dimethoxyethane, and 1,4-dioxane are preferable, and tetrahydrofuran is more preferable.
- the amount used is not particularly limited, but is preferably in the range of 1 to 100 times by mass, more preferably 3 to 50 times by mass, based on the 1,4-gen-3-one derivative. Range.
- the 1,4-gen_3-one derivative is stereoselectively reduced so that the hydrogen atom at the 5-position of predanane is in the 0! Configuration.
- stereoselective means that the compound (I) and the compound (I I) are produced more than isomers in which the hydrogen atom at the 5-position of predanane is in the / 3 configuration.
- the method for isolating and purifying the product after the reaction is not particularly limited, and a method usually used for isolating and purifying an organic compound can be employed. For example, if necessary, after deprotection of a hydroxyl-protecting group, an extraction operation or the like is performed, and the mixture is concentrated to obtain a mixture of compound (I) and compound (II) or compound (IV) and compound (IV). Compound (V) can be obtained.
- a 21-dihydroxy-1 20-methyl predaner 1,4—1-3-one which is a raw material of a 1,4-gen-3-one derivative, is 3a , 7 ⁇ -dihydroxy-1 5)
- 3-cholanic acid and ⁇ or a salt thereof are subjected to a conversion reaction using a microorganism (JP- ⁇ -25525049) to give 7-hydroxy-3-oxopregna-1 1,4-Igen _ 20 Induced to ⁇ -carbaldehyde, and further Can be easily obtained by reducing the 20-position with sodium borohydride (WO02Z20552), and
- (2 OS) -7 a, 21-dihydroxy-l-monomethylpredaner 4-en-3-one is 3 alpha, 7 alpha-dihydroxy-one 5 one cholanic acid 7 by subjecting a conversion reaction using a microorganism alpha - hydroxy-3 - O Kisopureguna induced to a 4 one
- the reaction solution was cooled to room temperature, the pH of the aqueous layer was adjusted to 8 with a 10% by mass aqueous sodium hydroxide solution, and then the organic layer was separated and concentrated.
- the obtained crude product was purified by silica gel column chromatography, and (20S) -7a, 21-dihydroxy-20-methyl-5 ⁇ -predana-3-one ( 3.15 g) was obtained (yield 94%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006511886A JPWO2005095432A1 (ja) | 2004-03-31 | 2005-03-31 | 5α−プレグナン誘導体の製造方法 |
US10/594,401 US20070203106A1 (en) | 2005-03-31 | 2005-03-31 | Method for Producing 5Alpha-Pregnane Derivative |
EP05728912A EP1731526A4 (en) | 2004-03-31 | 2005-03-31 | METHOD OF PREPARING A 5-ALPHA PRIMING DERIVATIVE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-108443 | 2004-03-31 | ||
JP2004108443 | 2004-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005095432A1 true WO2005095432A1 (ja) | 2005-10-13 |
Family
ID=35063715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/006819 WO2005095432A1 (ja) | 2004-03-31 | 2005-03-31 | 5α-プレグナン誘導体の製造方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1731526A4 (ja) |
JP (1) | JPWO2005095432A1 (ja) |
CN (1) | CN100509839C (ja) |
WO (1) | WO2005095432A1 (ja) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS568399A (en) * | 1979-04-12 | 1981-01-28 | Hoffmann La Roche | Manufacture of chenodeoxycholic acid |
WO2002050552A1 (fr) * | 2000-12-18 | 2002-06-27 | Ngk Insulators, Ltd. | Procede de formation de points de detection dans des puces servant a detecter des sujets |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60123939T2 (de) * | 2000-04-12 | 2007-05-31 | Genaera Corp. | Ein verfahren zur herstellung von 7.alpha.-hydroxy 3-aminosubstituierten sterol-verbindungen, ohne schutz der 7.alpha.-hydroxy-gruppe |
CA2416850A1 (en) * | 2000-09-08 | 2003-01-20 | Kuraray Co., Ltd. | Process for the preparation of pregnane derivatives |
-
2005
- 2005-03-31 JP JP2006511886A patent/JPWO2005095432A1/ja not_active Withdrawn
- 2005-03-31 WO PCT/JP2005/006819 patent/WO2005095432A1/ja active Application Filing
- 2005-03-31 CN CNB2005800103295A patent/CN100509839C/zh not_active Expired - Fee Related
- 2005-03-31 EP EP05728912A patent/EP1731526A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS568399A (en) * | 1979-04-12 | 1981-01-28 | Hoffmann La Roche | Manufacture of chenodeoxycholic acid |
WO2002050552A1 (fr) * | 2000-12-18 | 2002-06-27 | Ngk Insulators, Ltd. | Procede de formation de points de detection dans des puces servant a detecter des sujets |
Non-Patent Citations (2)
Title |
---|
KIM H.S. ET AL: "Synthesis and antimicrobial activity of squalamine analogue.", BIOORGANIC & MEDICINAL CHEMISTRY., vol. 8, no. 8, 2000, pages 2059 - 2065, XP002949909 * |
See also references of EP1731526A4 * |
Also Published As
Publication number | Publication date |
---|---|
CN1938331A (zh) | 2007-03-28 |
JPWO2005095432A1 (ja) | 2008-02-21 |
EP1731526A1 (en) | 2006-12-13 |
CN100509839C (zh) | 2009-07-08 |
EP1731526A4 (en) | 2009-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5274453B2 (ja) | 17α−アセトキシ−11β−[4−(N、N−ジメチル−アミノ)−フェニル]−19−ノルプレグナ−4,9−ジエン−3,20−ジオンの合成のための工業的プロセスおよびプロセスの新規中間体 | |
US8524693B2 (en) | Process for obtaining 17-spirolactones in steroids | |
KR20240135777A (ko) | 고순도 식물 유래 콜레스테롤의 합성방법 | |
CN115884978A (zh) | 制备胆酸衍生物的方法及其原料 | |
US9296780B2 (en) | Process for alkynylating 16-substituted-17-keto steroids | |
CN103804456B (zh) | 醋酸乌利司他中间体及其制备方法 | |
JPWO2005095434A1 (ja) | 5α−プレグナン誘導体の製造方法 | |
WO2014040457A1 (zh) | 一种制备利马前列素的中间体、其制备方法以及通过其制备利马前列素的方法 | |
WO2005095431A1 (ja) | 5α-プレグナン誘導体の製造方法 | |
WO2005095432A1 (ja) | 5α-プレグナン誘導体の製造方法 | |
WO2019170521A1 (en) | Synthesis of obeticholic acid and synthesis intermediate | |
US20070203106A1 (en) | Method for Producing 5Alpha-Pregnane Derivative | |
JPWO2005095433A1 (ja) | 5α−プレグナン誘導体の製造方法 | |
JP2005314405A (ja) | 5α−プレグナン誘導体の製造方法 | |
US9683010B2 (en) | Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives | |
JPWO2003080561A1 (ja) | ボグリボースの製造法 | |
JP5115762B2 (ja) | 4−ホルミルピペリジンアセタール誘導体の製造方法 | |
JP2000256244A (ja) | 4−メチルテトラフルオロベンジルアルコール誘導体の製造法 | |
US9562067B2 (en) | Process for the production of 19-norpregn-4-en-3,20-dione-17α-ol(gestonorone) and intermediates therefor | |
JPS623840B2 (ja) | ||
JP2005289901A (ja) | 5α−プレグナン誘導体の製造方法 | |
CN113024589A (zh) | 艾日布林及其中间体的制备方法 | |
EP0058071A2 (en) | Process and intermediates for preparing pirbuterol | |
JPH07300470A (ja) | dl−トコフェロール類の製造法および製造用中間体 | |
JPH05148187A (ja) | 新規なシクロブタン誘導体及びその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006511886 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10594401 Country of ref document: US Ref document number: 2007203106 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580010329.5 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005728912 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4001/CHENP/2006 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005728912 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10594401 Country of ref document: US |